Old Web
English
Sign In
Acemap
>
Paper
>
Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study
Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study
2021
Claude Negrier
Johnny Mahlangu
Michaela Lehle
Pratima Chowdary
Olivier Catalani
Victor Jiménez Yuste
Benjamin M. Beckermann
Christophe Schmitt
Cédric Hermans
Giuliana Ventriglia
Jerzy Windyga
Anna Kiialainen
Roseline dOiron
Paul Moorehead
Vanda Teodoro
Amy D. Shapiro
Johannes Oldenburg
Keywords:
Haven
Interim analysis
Pediatrics
Emicizumab
Medicine
Moderate hemophilia A
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]